CtrlK
PharmaCyte Biotech
PMCB52
$1.32arrow_drop_up2.23%$0.02
NASDAQ - As of Apr 4, 4:14 AM EDT Market Closed
High Value
Penny Stock
PMCB52
$1.32
arrow_drop_up2.23%Performance History
arrow_drop_down48.76%
(-$1.18 )
| Key Stats | |
|---|---|
| Open | $1.30 |
| Prev. Close | $1.30 |
| EPS | 0.88 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $8.51M |
| PE Ratio | 1.51 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 1.23 | 1.35 |
| 52 Week Range | 1.23 | 2.58 |
| Ratios | |
|---|---|
| P/B Ratio | 0.28 |
| Revenue | - |
| Operating M. % | 0.00% |
| Earnings | $333.76K |
| Earnings Growth % | 107.73% |
| EBITDA Margin % | - |
| ROE % | 43.18% |
| EPS | 0.88 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About PharmaCyte Biotech (PMCB)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Joshua N. Silverman
- Headquarters
- Las Vegas
- Employees
- 2
- Exchange
- NASDAQ
Keep an eye on PharmaCyte Biotech
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is PharmaCyte Biotech's (PMCB) price per share?
The current price per share for PharmaCyte Biotech (PMCB) is $1.33. The stock has seen a price change of $0.03 recently, indicating a 2.23% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for PharmaCyte Biotech (PMCB)?
For PharmaCyte Biotech (PMCB), the 52-week high is $2.58, which is 94.13% from the current price. The 52-week low is $1.23, the current price is 8.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is PharmaCyte Biotech (PMCB) a growth stock?
PharmaCyte Biotech (PMCB) has shown an average price growth of -1.65% over the past three years. It has received a score of 37 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying PharmaCyte Biotech as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is PharmaCyte Biotech (PMCB) stock price performance year to date (YTD)?
As of the latest data, PharmaCyte Biotech (PMCB) has a year-to-date price change of -15.35%. Over the past month, the stock has experienced a price change of -22.28%. Over the last three months, the change has been -18.96%. Over the past six months, the figure is -23.18%.
help
Is PharmaCyte Biotech (PMCB) a profitable company?
PharmaCyte Biotech (PMCB) has a net income of $333.76K, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$6.52M. Furthermore, the EBITDA is $0.
help
What is the market capitalization of PharmaCyte Biotech (PMCB)?
PharmaCyte Biotech (PMCB) has a market capitalization of $8.51M. The average daily trading volume is 1.27, indicating the stock's liquidity and investor engagement.